ESG And Sustainability Tear Sheet

Overview

The report describes Rocket Pharmaceuticals' 2024 sustainability disclosures across employee engagement, diversity, health and safety, patients and community, environment, and governance. It reports Scope 1 emissions of 611 MT CO2e and Scope 2 emissions of 2,206 MT CO2e, alongside gas and electricity consumption. Environmental initiatives included repurposing 33% of lab-material inventory and recycling 181 drums and 130 pallets. Governance disclosures describe a management-level Sustainability Steering Committee overseeing sustainability practices and reporting.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Condensed report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services